Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981509063> ?p ?o ?g. }
- W1981509063 endingPage "249" @default.
- W1981509063 startingPage "244" @default.
- W1981509063 abstract "1. We have attempted to reduce dapsone-dependent methaemoglobinaemia formation in six dermatitis herpetiformis patients stabilised on dapsone by the co-administration of cimetidine. 2. In comparison with control, i.e. dapsone alone, methaemoglobinaemia due to dapsone fell by 27.3 +/- 6.7% and 26.6 +/- 5.6% the first and second weeks after commencement of cimetidine administration. The normally cyanotic appearance of the patient on the highest dose of dapsone (350 mg day- 1), underwent marked improvement. 3. There was a significant increase in the trough plasma concentration of dapsone (2.8 +/- 0.8 x 10(-5)% dose ml-1) at day 21 in the presence of cimetidine compared with control (day 7, 1.9 +/- 0.6 x 10(-5)% dose ml-1, P less than 0.01). During the period of the study, dapsone-mediated control of the dermatitis herpetiformis in all six patients was unchanged. 4. Trough plasma concentrations of monoacetyl dapsone were significantly increased (P less than 0.05) at day 21 (1.9 +/- 1.0 x 10(-5)% dose ml- 1) compared with day 7 (1.6 +/- 0.9 x 10(-5)% dose ml-1:control). 5. Over a 12 h period, 20.6 +/- 8.9% (day 0) of a dose of dapsone was detectable in urine as dapsone hydroxylamine. Significantly less dapsone hydroxylamine was recovered from urine at day 14 (15.0 +/- 8.4) in the presence of cimetidine, compared with day 0 (control: P less than 0.05). 6. The co-administration of cimetidine may be of value in increasing patient tolerance to dapsone, a widely used, effective, but comparatively toxic drug." @default.
- W1981509063 created "2016-06-24" @default.
- W1981509063 creator A5014216602 @default.
- W1981509063 creator A5026219635 @default.
- W1981509063 creator A5029953424 @default.
- W1981509063 creator A5041983500 @default.
- W1981509063 creator A5043029347 @default.
- W1981509063 creator A5058823559 @default.
- W1981509063 creator A5065605936 @default.
- W1981509063 date "1992-09-01" @default.
- W1981509063 modified "2023-09-30" @default.
- W1981509063 title "The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients." @default.
- W1981509063 cites W1504205760 @default.
- W1981509063 cites W1531592606 @default.
- W1981509063 cites W1690918147 @default.
- W1981509063 cites W1752699147 @default.
- W1981509063 cites W1900559920 @default.
- W1981509063 cites W1973320184 @default.
- W1981509063 cites W1976217151 @default.
- W1981509063 cites W1982280585 @default.
- W1981509063 cites W1996367778 @default.
- W1981509063 cites W1997122263 @default.
- W1981509063 cites W2000900010 @default.
- W1981509063 cites W2002862317 @default.
- W1981509063 cites W2028117616 @default.
- W1981509063 cites W2034903871 @default.
- W1981509063 cites W2037727265 @default.
- W1981509063 cites W2038038947 @default.
- W1981509063 cites W2038076828 @default.
- W1981509063 cites W2046309551 @default.
- W1981509063 cites W2050169783 @default.
- W1981509063 cites W2050761831 @default.
- W1981509063 cites W2064147984 @default.
- W1981509063 cites W2068076625 @default.
- W1981509063 cites W2094805343 @default.
- W1981509063 cites W2125227595 @default.
- W1981509063 cites W2165308110 @default.
- W1981509063 cites W2168327138 @default.
- W1981509063 cites W2201841785 @default.
- W1981509063 cites W2296797125 @default.
- W1981509063 cites W2399873586 @default.
- W1981509063 cites W2406325030 @default.
- W1981509063 cites W2409758653 @default.
- W1981509063 cites W2415530597 @default.
- W1981509063 cites W32365366 @default.
- W1981509063 cites W4250754784 @default.
- W1981509063 doi "https://doi.org/10.1111/j.1365-2125.1992.tb04131.x" @default.
- W1981509063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1381395" @default.
- W1981509063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1389948" @default.
- W1981509063 hasPublicationYear "1992" @default.
- W1981509063 type Work @default.
- W1981509063 sameAs 1981509063 @default.
- W1981509063 citedByCount "94" @default.
- W1981509063 countsByYear W19815090632012 @default.
- W1981509063 countsByYear W19815090632013 @default.
- W1981509063 countsByYear W19815090632015 @default.
- W1981509063 countsByYear W19815090632016 @default.
- W1981509063 countsByYear W19815090632017 @default.
- W1981509063 countsByYear W19815090632018 @default.
- W1981509063 countsByYear W19815090632019 @default.
- W1981509063 countsByYear W19815090632020 @default.
- W1981509063 countsByYear W19815090632021 @default.
- W1981509063 countsByYear W19815090632022 @default.
- W1981509063 countsByYear W19815090632023 @default.
- W1981509063 crossrefType "journal-article" @default.
- W1981509063 hasAuthorship W1981509063A5014216602 @default.
- W1981509063 hasAuthorship W1981509063A5026219635 @default.
- W1981509063 hasAuthorship W1981509063A5029953424 @default.
- W1981509063 hasAuthorship W1981509063A5041983500 @default.
- W1981509063 hasAuthorship W1981509063A5043029347 @default.
- W1981509063 hasAuthorship W1981509063A5058823559 @default.
- W1981509063 hasAuthorship W1981509063A5065605936 @default.
- W1981509063 hasBestOaLocation W19815090632 @default.
- W1981509063 hasConcept C126322002 @default.
- W1981509063 hasConcept C16005928 @default.
- W1981509063 hasConcept C2777640609 @default.
- W1981509063 hasConcept C2778728583 @default.
- W1981509063 hasConcept C2779134260 @default.
- W1981509063 hasConcept C2780026642 @default.
- W1981509063 hasConcept C2780719153 @default.
- W1981509063 hasConcept C42219234 @default.
- W1981509063 hasConcept C71924100 @default.
- W1981509063 hasConcept C90924648 @default.
- W1981509063 hasConcept C98274493 @default.
- W1981509063 hasConceptScore W1981509063C126322002 @default.
- W1981509063 hasConceptScore W1981509063C16005928 @default.
- W1981509063 hasConceptScore W1981509063C2777640609 @default.
- W1981509063 hasConceptScore W1981509063C2778728583 @default.
- W1981509063 hasConceptScore W1981509063C2779134260 @default.
- W1981509063 hasConceptScore W1981509063C2780026642 @default.
- W1981509063 hasConceptScore W1981509063C2780719153 @default.
- W1981509063 hasConceptScore W1981509063C42219234 @default.
- W1981509063 hasConceptScore W1981509063C71924100 @default.
- W1981509063 hasConceptScore W1981509063C90924648 @default.
- W1981509063 hasConceptScore W1981509063C98274493 @default.
- W1981509063 hasIssue "3" @default.
- W1981509063 hasLocation W19815090631 @default.
- W1981509063 hasLocation W19815090632 @default.